The 6-month formulation was launched in Germany in March 2007following its approval in December 2006. Eligard is already approved inGermany and other European countries for the one-month (7.5 mg) ...
In what its chairman and CEO called a “transforming event” for the company, Atrix Laboratories Inc. received FDA approval for Eligard 7.5 mg, its one-month treatment for advanced prostate cancer. The ...
Co announces that the European approval procedure for the Eligard 45 mg six-month formulation was successfully completed. Launch of this formulation in 23 European countries is expected to follow the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback